Different from traditional antibody development technology, Oneness has established a phage display library of fully human antibodies which enable us to generate antibodies with high affinity and specificity in an efficient manner. This library is with 2X1011 clones and the diversity and quality of the antibodies have been confirmed by analyzing over 500 fragments of DNA sequence. Based on our efficiency antibody screening platform, we have successfully screened antibodies that are with high affinity and potential. Among the screened antibodies, FB704A has completed Phase 1 study, and FB918 and SNS01 have been undergoing discovery/preclinical development. It is believed that the value of this library will keep growing along with the development of new drugs.